ASSESSMENT OF THE QUALITY OF LIFE OF PATIENTS WITH LUNG CANCER IN THE ABAY REGION
Background and Objectives. Lung cancer is the leading cause of cancer-related mortality worldwide. Due to late-stage diagnosis, the five-year survival rate remains as low as 15%. Disease progression, symptom severity, and treatment-related adverse effects significantly diminish the quality of life (QoL) in these patients. The objective of this study was to assess the quality of life in patients with lung cancer.
Materials and Methods. This prospective study was conducted from May to October 2024 in the Abay region of the Republic of Kazakhstan and included 123 patients diagnosed with lung cancer. Patient-reported quality of life and symptom burden were evaluated using the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 (EORTC QLQ-C30), with scores ranging from 0 to 100.
Results. Overall quality of life (mean score > 50) and functional scales (mean score > 50) were moderate to good. The highest mean score was observed for social functioning (94±11.3), followed by physical functioning (79.73±13.3), cognitive functioning (76.15±19.5), emotional functioning (74.08±22.6), and role functioning (67±15.4).
Conclusions. This study highlights the necessity of conducting multicenter research to assess quality of life in larger populations of lung cancer patients. It underscores that patient-reported outcomes regarding quality of life should be considered essential in developing new healthcare strategies aimed at improving medical care, including treatment, rehabilitation, and palliative support for oncology patients.
Количество просмотров: 1098
Категория статей:
Оригинальное исследование
Библиографическая ссылка
Adilgazyuly Sh., Bulegenov T., Mussakhanova A., Altybayeva Zh., Medeulova A., Tokenova Zh., Urazalina N.M. Assessment of the quality of life of patients with lung cancer in the Abay region // Nauka i Zdravookhranenie [Science & Healthcare]. 2025. Vol.27 (1), pp. 26-31. doi 10.34689/SH.2024.27.1.003Похожие публикации:
REPROGRAMMING EXPERIENCE OF BLOOD MONONUCLEAR CELLS INTO INDUCED PLURIPOTENT STEM CELLS (IPSCS) IN A PATIENT WITH CATECHOLAMINERGIC POLYMORPHIC VENTRICULAR TACHYCARDIA (CPVT)
CREATION OF THE PREGNANCY MICE MODEL TO STUDY THE EFFECT OF GLP-1/GIP AGONISTS
SATISFACTION WITH THE QUALITY OF PRIMARY CARE FOR PATIENTS WITH HYPERTENSION
EPIDEMIOLOGY, RESOURCE DISTRIBUTION, AND MANAGEMENT CHALLENGES OF CHRONIC HEART FAILURE IN KAZAKHSTAN: A NATIONAL RETROSPECTIVE ANALYSIS
PREVALENCE OF POLYMORPHISMS IN WARFARIN METABOLISM-RELATED GENES AMONG THE KAZAKH POPULATION